Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J Virol Methods, 163: 505-508 (2010).

Publication Latest Publications

Title: Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1
Authors: Wallis CL, Papathanasopoulos MA, Lakhi S, Karita E, Kamali A, Kaleebu P, Sanders E, Anzala O, Bekker LG, Stevens G, De Wit TF, Stevens W .
Journal: J Virol Methods,163:505-508 (2010)

Journal Impact Factor (I.F.): 2.065
Number of citations (Google Scholar): 31

Abstract

Download: Full text paper

Citation: Wallis CL, Papathanasopoulos MA, Lakhi S, Karita E, Kamali A, Kaleebu P, Sanders E, Anzala O, Bekker LG, Stevens G, De Wit TF, Stevens W . Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1 J Virol Methods,163:505-508 (2010).


Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Journal: EBioMedicine (2017)

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013